165 related articles for article (PubMed ID: 21813631)
1. Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.
Aragaki M; Takahashi K; Akiyama H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Sep; 17(18):5889-900. PubMed ID: 21813631
[TBL] [Abstract][Full Text] [Related]
2. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.
Masuda K; Takano A; Oshita H; Akiyama H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Dec; 17(24):7712-22. PubMed ID: 22016508
[TBL] [Abstract][Full Text] [Related]
3. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
[TBL] [Abstract][Full Text] [Related]
5. Activation of WD repeat and high-mobility group box DNA binding protein 1 in pulmonary and esophageal carcinogenesis.
Sato N; Koinuma J; Fujita M; Hosokawa M; Ito T; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2010 Jan; 16(1):226-39. PubMed ID: 20028748
[TBL] [Abstract][Full Text] [Related]
6. Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients.
Kato T; Sato N; Takano A; Miyamoto M; Nishimura H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2008 Apr; 14(8):2363-70. PubMed ID: 18413826
[TBL] [Abstract][Full Text] [Related]
7. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer.
Ishikawa N; Daigo Y; Takano A; Taniwaki M; Kato T; Tanaka S; Yasui W; Takeshima Y; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
Cancer Sci; 2006 Aug; 97(8):737-45. PubMed ID: 16863507
[TBL] [Abstract][Full Text] [Related]
8. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.
Furukawa C; Daigo Y; Ishikawa N; Kato T; Ito T; Tsuchiya E; Sone S; Nakamura Y
Cancer Res; 2005 Aug; 65(16):7102-10. PubMed ID: 16103059
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
10. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
[TBL] [Abstract][Full Text] [Related]
11. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
12. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
13. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
16. Identification of COX17 as a therapeutic target for non-small cell lung cancer.
Suzuki C; Daigo Y; Kikuchi T; Katagiri T; Nakamura Y
Cancer Res; 2003 Nov; 63(21):7038-41. PubMed ID: 14612491
[TBL] [Abstract][Full Text] [Related]
17. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
19. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
20. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
Kanai R; Eguchi K; Takahashi M; Goldman S; Okano H; Kawase T; Yazaki T
J Gene Med; 2006 Nov; 8(11):1329-40. PubMed ID: 16955534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
